Teza Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-56,826
| Closed | -$2.94M | – | 528 |
|
2024
Q3 | $2.94M | Sell |
56,826
-9,241
| -14% | -$478K | 0.32% | 81 |
|
2024
Q2 | $2.74M | Buy |
+66,067
| New | +$2.74M | 0.34% | 80 |
|
2024
Q1 | – | Sell |
-29,021
| Closed | -$1.49M | – | 575 |
|
2023
Q4 | $1.49M | Buy |
29,021
+17,496
| +152% | +$898K | 0.25% | 125 |
|
2023
Q3 | $669K | Sell |
11,525
-29,018
| -72% | -$1.68M | 0.11% | 263 |
|
2023
Q2 | $2.59M | Buy |
+40,543
| New | +$2.59M | 0.42% | 62 |
|
2023
Q1 | – | Sell |
-4,832
| Closed | -$348K | – | 517 |
|
2022
Q4 | $348K | Buy |
+4,832
| New | +$348K | 0.07% | 413 |
|
2022
Q3 | – | Sell |
-10,774
| Closed | -$830K | – | 538 |
|
2022
Q2 | $830K | Sell |
10,774
-19,526
| -64% | -$1.5M | 0.32% | 106 |
|
2022
Q1 | $2.21M | Buy |
30,300
+6,413
| +27% | +$468K | 0.83% | 18 |
|
2021
Q4 | $1.49M | Buy |
+23,887
| New | +$1.49M | 0.4% | 60 |
|
2021
Q3 | – | Sell |
-35,700
| Closed | -$2.39M | – | 370 |
|
2021
Q2 | $2.39M | Sell |
35,700
-45,239
| -56% | -$3.02M | 0.39% | 78 |
|
2021
Q1 | $5.11M | Buy |
80,939
+73,375
| +970% | +$4.63M | 1.02% | 13 |
|
2020
Q4 | $469K | Sell |
7,564
-14,356
| -65% | -$890K | 0.27% | 130 |
|
2020
Q3 | $1.32M | Buy |
+21,920
| New | +$1.32M | 0.77% | 21 |
|
2018
Q4 | – | Sell |
-21,336
| Closed | -$1.33M | – | 341 |
|
2018
Q3 | $1.33M | Buy |
21,336
+2,694
| +14% | +$167K | 0.31% | 119 |
|
2018
Q2 | $1.03M | Buy |
18,642
+5,994
| +47% | +$332K | 0.15% | 210 |
|
2018
Q1 | $800K | Sell |
12,648
-1,141
| -8% | -$72.2K | 0.19% | 211 |
|
2017
Q4 | $845K | Buy |
+13,789
| New | +$845K | 0.51% | 37 |
|